Avinger, Inc. (AVGR): Price and Financial Metrics

Avinger, Inc. (AVGR): $1.25

-0.01 (-0.80%)

POWR Rating

Component Grades













AVGR Stock Summary

  • AVGR has a higher market value than only 2.92% of US stocks; more precisely, its current market capitalization is $9,517,624.
  • As for revenue growth, note that AVGR's revenue has grown -17.06% over the past 12 months; that beats the revenue growth of just 9.78% of US companies in our set.
  • The volatility of AVINGER INC's share price is greater than that of 93.43% US stocks with at least 200 days of trading history.
  • If you're looking for stocks that are quantitatively similar to AVINGER INC, a group of peers worth examining would be WAVE, DAKT, UPC, ITRN, and VOXX.
  • AVGR's SEC filings can be seen here. And to visit AVINGER INC's official web site, go to www.avinger.com.

AVGR Valuation Summary

  • In comparison to the median Healthcare stock, AVGR's price/sales ratio is 77.08% lower, now standing at 1.1.
  • Over the past 95 months, AVGR's price/sales ratio has gone down 10.8.

Below are key valuation metrics over time for AVGR.

Stock Date P/S P/B P/E EV/EBIT
AVGR 2022-11-25 1.1 1.9 -0.3 -0.3
AVGR 2022-11-23 1.0 1.8 -0.3 -0.3
AVGR 2022-11-22 0.9 1.6 -0.3 -0.3
AVGR 2022-11-21 0.9 1.5 -0.3 -0.2
AVGR 2022-11-18 0.9 1.6 -0.3 -0.3
AVGR 2022-11-17 1.0 1.7 -0.3 -0.3

AVGR Growth Metrics

    The 5 year price growth rate now stands at -99.96%.
  • The year over year price growth rate now stands at -90.08%.
  • Its year over year net cashflow from operations growth rate is now at -16.41%.
AVGR's revenue has moved down $456,000 over the prior 33 months.

The table below shows AVGR's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 8.675 -17.574 -27.972
2022-06-30 8.789 -17.7 -28.714
2022-03-31 9.459 -17.075 -26.869
2021-12-31 10.13 -15.697 -21.587
2021-09-30 10.459 -15.33 -21.143
2021-06-30 10.395 -14.984 -20.679

AVGR's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • AVGR has a Quality Grade of D, ranking ahead of 16.95% of graded US stocks.
  • AVGR's asset turnover comes in at 0.276 -- ranking 136th of 186 Medical Equipment stocks.
  • HOLX, ICAD, and BTCY are the stocks whose asset turnover ratios are most correlated with AVGR.

The table below shows AVGR's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.276 0.353 -1.054
2021-03-31 0.257 0.332 -1.360
2020-12-31 0.288 0.299 -1.795
2020-09-30 0.306 0.298 -2.297
2020-06-30 0.336 0.303 -2.235
2020-03-31 0.369 0.314 -1.990

AVGR Price Target

For more insight on analysts targets of AVGR, see our AVGR price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $2.50 Average Broker Recommendation 1.5 (Moderate Buy)

AVGR Stock Price Chart Interactive Chart >

Price chart for AVGR

AVGR Price/Volume Stats

Current price $1.25 52-week high $11.99
Prev. close $1.26 52-week low $0.94
Day low $1.22 Volume 47,700
Day high $1.28 Avg. volume 107,754
50-day MA $1.13 Dividend yield N/A
200-day MA $2.07 Market Cap 9.30M

Avinger, Inc. (AVGR) Company Bio

Avinger, Inc. designs, manufactures, and sells image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease in the United States and Europe. The company was founded in 2007 and is based in Redwood City, California.

AVGR Latest News Stream

Event/Time News Detail
Loading, please wait...

AVGR Latest Social Stream

Loading social stream, please wait...

View Full AVGR Social Stream

Latest AVGR News From Around the Web

Below are the latest news stories about AVINGER INC that investors may wish to consider to help them evaluate AVGR as an investment opportunity.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

We're starting off the day with a look at the biggest pre-market stock movers that traders will want to know about for Tuesday morning!

William White on InvestorPlace | November 15, 2022

Avinger Third Quarter 2022 Earnings: US$0.77 loss per share (vs US$1.25 loss in 3Q 2021)

Avinger ( NASDAQ:AVGR ) Third Quarter 2022 Results Key Financial Results Revenue: US$2.25m (down 4.8% from 3Q 2021...

Yahoo | November 12, 2022

Avinger Reports Third Quarter 2022 Results

Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular disease, today reported results for the third quarter ended September 30, 2022.

Yahoo | November 9, 2022

Avinger Announces Issuance of Seven New Patents Expanding Coverage for Its Proprietary Image-Guided Atherectomy Devices

Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular disease, today announced the issuance of seven new U.S.

Yahoo | November 4, 2022

Avinger to Announce Third Quarter 2022 Results on November 9

Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of vascular disease, today announced that it will release its financial results for the third quarter 2022 after the close of trading on Wednesday, November 9, 2022.

Yahoo | November 1, 2022

Read More 'AVGR' Stories Here

AVGR Price Returns

1-mo 26.29%
3-mo N/A
6-mo -25.15%
1-year -87.75%
3-year -95.63%
5-year -99.93%
YTD -86.11%
2021 2.25%
2020 -61.39%
2019 -62.00%
2018 -95.83%
2017 -95.14%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.7557 seconds.